Amerikanische Gesellschaft für Hirudotherapie

Leech therapy in cutaneous surgery and disease

Review and case series published in J Drugs Dermatol (2010)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Case reportKlinische StudienSicherheit & InfektionskontrolleMamelak AJ et al. · Journal of drugs in dermatology, 2010

Abstract

BACKGROUND: Over the ages, the use of leeches in medicine has evolved from haphazard bloodletting to a well-understood physiologic process with defined, rational applications. OBJECTIVE: The authors describe the current role of leech therapy in cutaneous surgery and medicine. METHODS: Case series and review of the literature. RESULTS: Leech saliva contains anticoagulative, anti-aggregative and vasodilatory components. Combined with the annelid's mechanical ability to extract blood, leeches can contribute to patients' health with minimal risks. CONCLUSION: Leeches should be considered as novel therapies for disorders of coagulation and venous congestion. Implementation of leech treatment should be tempered with the potential adverse effects, including Aeromonas infection and a drop in hematocrit that might require a blood transfusion.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal Article
Indexed MeSH termsAnimalsChild, PreschoolFemaleHumansLeechingMaleMiddle AgedMohs SurgeryPurpura FulminansSkin DiseasesSurgical Flaps

Zusammenfassung

Case series and literature review of leech therapy in cutaneous surgery and dermatologic disease. Documents anticoagulative, anti-aggregative, and vasodilatory components of leech saliva alongside Aeromonas/transfusion risks.

Warum dies für die Hirudotherapie relevant ist

This article presents case reports and a literature review describing the current role of leech therapy in cutaneous surgery and medicine, highlighting that leech saliva contains anticoagulative, anti-aggregative, and vasodilatory components that, combined with mechanical blood extraction, can benefit patients with minimal risks. The authors conclude that leeches should be considered for disorders of coagulation and venous congestion, while cautioning about potential Aeromonas infection and hematocrit drops requiring transfusion. This is directly relevant to ASH's domain as it addresses clinical hirudotherapy applications and safety. However, as a case series and literature review, it lacks controlled trial data, and the abstract does not specify the number of cases or provide quantitative outcomes.

Zitation

Leech therapy in cutaneous surgery and disease.

Mamelak AJ et al. · Journal of drugs in dermatology, 2010

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.